U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07757620) titled 'Epigenetic Changes in Long COVID Patients' on July 30. Brief Summary: The goal of this obs... Read More
Singapore, Aug. 12 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose St... Read More
Singapore, Aug. 12 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating ... Read More
Singapore, Aug. 12 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Pla... Read More
U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07758595) titled 'A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL921 in Healthy... Read More
Singapore, Aug. 12 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solut... Read More
Singapore, Aug. 12 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib M... Read More
U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07757607) titled 'A Prospective, Multicenter, Single-Arm Study to Support the Clinical Evidence Base for MRac... Read More
Singapore, Aug. 12 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib M... Read More
U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07757152) titled 'Phase I Clinical Study of ZL-65 Tablet in Healthy Adult Participants in China' on Aug. 05. ... Read More